Patent Oppositions in liquid medication solutions industry

Explore the competitive field of liquid medication solutions where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in liquid medication solutions technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the liquid medication solutions industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the liquid medication solutions industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 9, 2026LUMARA BIO ONCOLOGICS
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 9, 2026LUMARA BIO ONCOLOGICS
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSSep 9, 2026LUMARA BIO ONCOLOGICS
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 26, 2026HAMPTON KNOWLES
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 25, 2026BISCHOF & PARTNER
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 24, 2026SANDOZ
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 21, 2026ADVANZ PHARMA SERVICES UK
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2026KERNEBECK PATENTANWALTS
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSAug 19, 2026WITHERS & ROGERS
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 18, 2026STRAWMAN

To stay ahead in the competitive liquid medication solutions industry, companies are constantly innovating. Here are the top patents facing oppositions in the liquid medication solutions industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 26, 2025High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALS13
Feb 7, 2024Glp-1 Compositions And Uses ThereofNOVO NORDISK8
Aug 17, 2022Ready-To-Use Bortezomib SolutionSTADA ARZNEIMITTEL7
Sep 28, 2022Method For Producing A Bortezomib Ester SolutionSTADA ARZNEIMITTEL6
Sep 5, 2018Preservative Free Bimatoprost And Timolol SolutionsALLERGAN6
Jan 19, 2022Preservative Free Bimatoprost And Timolol SolutionsALLERGAN6
Mar 3, 2021Stabilized Antibody-Containing Liquid FormulationsCHUGAI SEIYAKU KABUSHIKI KAISHA5
Jun 17, 2015Fulvestrant FormulationASTRAZENECA5
Feb 12, 2020Formulations Of BendamustineEAGLE PHARMACEUTICALS4
Mar 16, 2016Injectable Suspensions Having Improved Injectability PropertiesALKERMES CONTROLLED THERAPEUTICS4